Using platelet-rich fibrin during cochlear implantation to reduce fibrosis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the application of autologous platelet-rich fibrin during cochlear implantation to mitigate fibrosis, which often limits the effectiveness of cochlear implants. The procedure involves applying the fibrin to the round window of the cochlea during surgery, followed by the implantation of the device. The study will monitor intraoperative neural response telemetry (NRT) and impedance measurements at various postoperative intervals to assess the impact of the treatment on implant functionality. The goal is to enhance the long-term performance of cochlear implants by reducing inflammation and fibrosis.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients with sensorineural hearing loss
* Patients who will have cochlear implant surgery with CI422 electrode

Exclusion Criteria:

* Patients with cochlear abnormality
* Patients with auditory neuropathy

Where it's running

• Pamukkale University
  Denizli, Turkey (Türkiye) Recruiting

Study contacts

• Study coordinator: Fazil N Ardic, MD
• Email: fnardic@pau.edu.tr
• Phone: 902582965799

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Long-term hearing and speech outcomes after cochlear implants

  This project will see if cochlear implants improve hearing, speech understanding, and quality of life in Mandarin-speaking patients of all ages before and after surgery.

  Recruiting Eye & ENT Hospital of Fudan University · Shanghai · NCT07380269

• Comparing domestic and imported hearing aids for age-related hearing loss

  This study is testing whether hearing aids made in the U.S. work better than imported ones for older adults with age-related hearing loss.

  Recruiting Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Guangzhou, Guangdong · NCT06882889

• Gene therapy for hearing loss caused by OTOF gene mutations

  This study is testing a new gene therapy to see if it can help children with hearing loss caused by OTOF gene mutations hear better.

  Recruiting at 2 sites Eye & ENT Hospital of Fudan University · Zhengzhou, Henan and 1 other locations · NCT06722170

• Using robotics and electrocochleography for cochlear implant surgery

  This study is testing if using a robotic system during cochlear implant surgery can help improve outcomes for people with hearing loss.

  Recruiting iotaMotion, Inc. · Iowa City, Iowa · NCT06664710

• Understanding listening effort in cochlear implant users

  This study tests how much effort people with cochlear implants need to understand speech compared to those with normal hearing, using speech tests and measuring pupil size to see how hard they are working to listen.

  Recruiting University of Minnesota · Minneapolis, Minnesota · NCT06516575

• Comparing experiences of over-the-counter and audiologist-fitted hearing aids

  This study looks at how people with mild-to-moderate hearing loss feel about using over-the-counter hearing aids compared to those fitted by an audiologist to see which option works better for their hearing and quality of life.

  Recruiting at 2 sites University of Iowa · Iowa City, Iowa and 1 other locations · NCT06499805

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.